normal human pulmonary arterial ecs (hpaecs) (Lonza)
Structured Review

Normal Human Pulmonary Arterial Ecs (Hpaecs), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/normal human pulmonary arterial ecs (hpaecs)/product/Lonza
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Single-Cell and Spatial Transcriptomics Identified Fatty Acid–Binding Proteins Controlling Endothelial Glycolytic and Arterial Programming in Pulmonary Hypertension"
Article Title: Single-Cell and Spatial Transcriptomics Identified Fatty Acid–Binding Proteins Controlling Endothelial Glycolytic and Arterial Programming in Pulmonary Hypertension
Journal: Arteriosclerosis, Thrombosis, and Vascular Biology
doi: 10.1161/ATVBAHA.124.321173
Figure Legend Snippet: Overexpression of FABP (fatty acid–binding protein) 4/5–induced endothelial cell (EC) dysfunction. A , Overexpression of FABP4 and FABP5 fused with Flag tag in human pulmonary arterial ECs (hPAECs) using lentiviruses mediated gene overexpression. B and C , FABP4/5 overexpression promoted ECs glycolysis and proliferation assessed by 5-bromo-20-deoxyuridine (BrdU) incorporation assay. D , Glycolytic inhibitor 2-DG treatment inhibited FABP4/5–induced PAEC proliferation. E , FABP4/5 deletion in vivo reduced lung PAECs proliferation in TKO mice compared with CKO mice. F and G , Overexpression of FABP4/5 promoted fatty acid oxidation (FAO) in hPAECs in the presence of palmitic acid. The double arrows label the OCR generation contributed by FAO. H , Both CPT1α inhibitor etomoxir (ETO, 20 µmol/L) and DNA synthesis inhibitor (5-FU, 20 µmol/L) blocked FABP4/5–induced EC proliferation. I and J , A representative seahorse data showing upregulation of FAO in PAECs isolated from patients with idiopathic PAH (IPAH) compared with control donors. Six lines of control or PAECs of patients with IPAH were tested. C , D , and H , For BrdU assay, each dot represents a biological replicate. The experiments were performed at least 3 times. Student t test ( D ). ANOVA followed by Tukey post hoc analysis was used for statistical analysis ( B , C , E , F , G , H , and J ). Significance levels were denoted as P <0.05. abs indicates absolute; A.U., arbitrary unit; Cap, capillary endothelial cells; DAPI, 4',6-diamidino-2-phenylindole; FD, false discovery; FDR, false discovery rate; Rep, replicate; and WT, wild type.
Techniques Used: Over Expression, Binding Assay, FLAG-tag, BrdU Incorporation Assay, In Vivo, DNA Synthesis, Isolation, Control, BrdU Staining
Figure Legend Snippet: HIF (hypoxia-inducible factor)-2α–mediated glycolysis induced by FABP (fatty acid–binding protein) 4/5 in pulmonary endothelial cells (ECs). A , A diagram showing the predicted transcription factors based on the DEGs and literature. B , Western blotting demonstrated HIF-2α but not p53 or c-Myc was upregulated in CKO lungs and normalized in TKO lungs. The β-actin on c-Myc blot was shared with Figure 1C FABP5. C , A representative heat map showed that glycolytic genes were dependent on HIF-2α using wild-type (WT), CKO mice, and Egln1 Tie2Cre /Hif2a Tie2Cre (EH2) mice. D , HIF-2α knockdown inhibited FABP4/5–induced endothelial proliferation. E , Nitrative stress assessed by protein nitrotyrosine modification was reduced in TKO lungs compared with CKO lungs. F , Overexpression of FABP4 and FABP5 promoted mitochondrial reactive oxygen species (ROS) levels in human pulmonary arterial EC (hPAECs). G , A diagram showing our proposed model. Our study addresses a novel role of lung endothelial FABP4/5 controlling PAEC accumulation through increased glycolysis in the pathogenesis of pulmonary arterial hypertension (PAH). By facilitating fatty acid uptake and translocation into mitochondria, FABP4/5 promote fatty acid oxidation (FAO) and ROS generation, which activates HIF-2α signaling to promote endothelial glycolysis. For 5-bromo-20-deoxyuridine (BrdU) assay in ( D ) and mitochondrial ROS assay in ( F ), each dot represents a biological replicate. The experiments were performed at least 3 times. ANOVA followed by Tukey post hoc analysis was used for statistical analysis ( B , D , E , and F ). Significance levels were denoted as P <0.05. α-NT indicates anti-nitrotyrosine; Adjp, adjusted P value; A.U., arbitrary unit; DAPI, 4',6-diamidino-2-phenylindole; DEG, differentially expressed gene; dNTP, deoxyribonucleotide triphosphate; ETO, etomoxir; 5-FU, 5-fluorouracil; siCTL, small interfering RNA control; siHIF, small interfering RNA targeting hypoxia-inducible factor; TF, transcription factor; and 2-DG, 2-deoxy-D-glucose.
Techniques Used: Binding Assay, Western Blot, Knockdown, Modification, Over Expression, Translocation Assay, BrdU Staining, ROS Assay, Small Interfering RNA, Control
